This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Generic Name
- Bismuth subcarbonate
- DrugBank Accession Number
- DB11281
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental, Vet approved
- Structure
Structure for Bismuth subcarbonate (DB11281)
- Weight
- Average: 509.967
Monoisotopic: 509.93537 - Chemical Formula
- CBi2O5
- Synonyms
- 2,4-Dioxa-1,5-dibismapentane, 1,3,5-trioxo-
- Bismuth carbonate
- Bismuth oxycarbonate
- Bismuth subcarbonate
- Bismuthyl carbonate
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your softwareAcetophenazine Acetophenazine may increase the neurotoxic activities of Bismuth subcarbonate. Alimemazine Alimemazine may increase the neurotoxic activities of Bismuth subcarbonate. Amisulpride Amisulpride may increase the neurotoxic activities of Bismuth subcarbonate. Amitriptyline Amitriptyline may increase the neurotoxic activities of Bismuth subcarbonate. Amitriptylinoxide Bismuth subcarbonate may increase the neurotoxic activities of Amitriptylinoxide. - Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Active Moieties
Name Kind UNII CAS InChI Key Bismuth cation ionic ZS9CD1I8YE 23713-46-4 JDIBGQFKXXXXPN-UHFFFAOYSA-N - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Estomarol Bismuth subcarbonate (0.21 g/3.5g) + Aluminum hydroxide (0.18 g/3.5g) + Calcium carbonate (0.25 g/3.5g) + Magnesium carbonate (0.59 g/3.5g) + Sodium bicarbonate (2.27 g/3.5g) Powder Oral Laboratorios Imperiales s.a. De c.v. 2011-05-11 Not applicable US 
Hemorro-dol Sup Bismuth subcarbonate (86.4 mg) + Balsam of Peru (22.6 mg) + Belladonna (11.25 mg) + Benzocaine (50 mg) + Bismuth subnitrate (37.8 mg) + Boric acid (226.7 mg) + Ephedrine sulfate (2.5 mg) + Zinc oxide (226.7 mg) Suppository Rectal Produits Francais Labs Inc. 1981-12-31 1997-05-30 Canada 
Sha-lem Bismuth subcarbonate (1.89 g/30mL) + Boric acid (0.95 g/30mL) + Oleic Acid (14.5 g/30mL) + Palmitic Acid (7.25 g/30mL) + Stearic acid (7.25 g/30mL) Ointment Topical Shalem Products, Inc. 1992-05-08 Not applicable US ยาน้ำขาว Bismuth subcarbonate (75 MG/15ML) + Calcium carbonate (750 MG/15ML) + Sodium bicarbonate (480 MG/15ML) Suspension ห้างหุ้นส่วนจำกัด ห้างขายยา กรุงเทพฯฟามาซี 1983-12-23 Not applicable Thailand 
- Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Sha-lem Bismuth subcarbonate (1.89 g/30mL) + Boric acid (0.95 g/30mL) + Oleic Acid (14.5 g/30mL) + Palmitic Acid (7.25 g/30mL) + Stearic acid (7.25 g/30mL) Ointment Topical Shalem Products, Inc. 1992-05-08 Not applicable US
Categories
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as organic carbonic acids. These are compounds comprising the carbonic acid functional group.
- Kingdom
- Organic compounds
- Super Class
- Organic acids and derivatives
- Class
- Organic carbonic acids and derivatives
- Sub Class
- Organic carbonic acids
- Direct Parent
- Organic carbonic acids
- Alternative Parents
- Carbonate salts / Organic salts / Organic oxides / Hydrocarbon derivatives / Carbonyl compounds / Organic cations
- Substituents
- Aliphatic acyclic compound / Carbonate salt / Carbonic acid / Carbonyl group / Hydrocarbon derivative / Organic cation / Organic oxide / Organic oxygen compound / Organic salt / Organooxygen compound
- Molecular Framework
- Aliphatic acyclic compounds
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- M41L2IN55T
- CAS number
- 5892-10-4
- InChI Key
- FWIZHMQARNODNX-UHFFFAOYSA-L
- InChI
- InChI=1S/CH2O3.2Bi.2O/c2-1(3)4;;;;/h(H2,2,3,4);;;;/q;2*+3;2*-2/p-2
- IUPAC Name
- dibismuth(3+) ion carbonate dioxidandiide
- SMILES
- [O--].[O--].[Bi+3].[Bi+3].[O-]C([O-])=O
References
- General References
- Not Available
- External Links
- ChemSpider
- 8003402
- 19475
- Wikipedia
- Bismuth_subcarbonate
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Powder Oral Suppository Rectal Ointment Topical Suspension - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 90.4 mg/mL ALOGPS logP -0.25 ALOGPS logP 0.25 Chemaxon logS -0.75 ALOGPS pKa (Strongest Acidic) 6.05 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 3 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 63.19 Å2 Chemaxon Rotatable Bond Count 0 Chemaxon Refractivity 31.17 m3·mol-1 Chemaxon Polarizability 3.52 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five No Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS splash10-00di-0000090000-4242897444bd4f95e8c3 - Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at December 03, 2015 16:52 / Updated at February 21, 2021 18:53